Wespac Advisors So Cal, LLC Elevance Health, Inc. Transaction History

Wespac Advisors So Cal, LLC

$426 Million
Q3 2024

A detailed history of Wespac Advisors So Cal, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Wespac Advisors So Cal, LLC holds 2,481 shares of ELV stock, worth $925,264. This represents 0.3% of its overall portfolio holdings.

Number of Shares

2,481

Previous 2,046 21.26%

Holding current value

$925,264

Previous $1.11 Million 16.43%

% of portfolio

0.3%

Previous 0.28%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$500.12 - $562.29 $217,552 - $244,596	435 Added 21.26%	2,481 $1.29 Million
Q2 2024 Jul 23, 2024	BUY	$497.49 - $547.8 $165,664 - $182,417	333 Added 19.44%	2,046 $1.11 Million
Q1 2024 Apr 18, 2024	BUY	$464.61 - $519.96 $69,691 - $77,994	150 Added 9.6%	1,713 $888,000
Q4 2023 Jan 25, 2024	BUY	$433.51 - $488.06 $104,042 - $117,134	240 Added 18.14%	1,563 $737,000
Q3 2023 Nov 09, 2023	SELL	$414.13 - $475.93 $49,695 - $57,111	-120 Reduced 8.32%	1,323 $576,000
Q2 2023 Jul 20, 2023	BUY	$436.33 - $496.2 $15,271 - $17,367	35 Added 2.49%	1,443 $641,000
Q1 2023 May 15, 2023	SELL	$446.3 - $502.2 $45,522 - $51,224	-102 Reduced 6.75%	1,408 $647,000
Q3 2022 Nov 10, 2022	SELL	$445.98 - $507.0 $45,043 - $51,207	-101 Reduced 6.27%	1,510 $826,000
Q2 2022 Jul 19, 2022	SELL	$444.32 - $529.84 $59,538 - $70,998	-134 Reduced 7.68%	1,611 $778,000
Q1 2022 May 19, 2022	SELL	$428.44 - $502.48 $36,417 - $42,710	-85 Reduced 4.64%	1,745 $857,000
Q4 2021 Feb 03, 2022	SELL	$370.08 - $467.67 $168 Million - $212 Million	-452,660 Reduced 99.6%	1,830 $803,000
Q4 2021 Feb 02, 2022	BUY	$370.08 - $467.67 $167 Million - $212 Million	452,500 Added 22738.69%	454,490 $6.7 Million
Q3 2021 Oct 14, 2021	SELL	$357.51 - $398.13 $66,139 - $73,654	-185 Reduced 8.51%	1,990 $743,000
Q2 2021 Jul 29, 2021	SELL	$352.19 - $401.9 $68,677 - $78,370	-195 Reduced 8.23%	2,175 $830,000
Q4 2020 Feb 02, 2021	SELL	$270.17 - $333.15 $29,718 - $36,646	-110 Reduced 4.44%	2,370 $761,000
Q3 2020 Oct 23, 2020	SELL	$245.73 - $284.63 $8,600 - $9,962	-35 Reduced 1.39%	2,480 $730,000
Q2 2020 Jul 17, 2020	SELL	$203.3 - $300.59 $62,006 - $91,679	-305 Reduced 10.82%	2,515 $641,000
Q1 2020 Apr 30, 2020	SELL	$174.68 - $307.74 $35,634 - $62,778	-204 Reduced 6.75%	2,820 $755,000
Q4 2019 Feb 13, 2020	BUY	$234.82 - $306.42 $24,421 - $31,867	104 Added 3.56%	3,024 $913,000
Q3 2019 Oct 17, 2019	BUY	$237.69 - $310.48 $80,814 - $105,563	340 Added 13.18%	2,920 $701,000
Q2 2019 Jul 30, 2019	BUY	$236.25 - $293.76 $585,900 - $728,524	2,480 Added 2480.0%	2,580 $728,000
Q3 2018 Oct 22, 2018	BUY	$238.27 - $274.12 $23,827 - $27,412	100 New	100 $27,000
Q2 2018 Jul 13, 2018	SELL	$220.13 - $245.16 $22,013 - $24,516	-100 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	100	100 $18,000

Others Institutions Holding ELV

# of Institutions

1,861

Shares Held

197M

Call Options Held

1.03M

Put Options Held

1.24M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $89.5B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.

Account

Wespac Advisors So Cal, LLC Elevance Health, Inc. Transaction History